BofA Securities

Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation

The North Texas-based precision oncology firm raised $494 million in its IPO. Founder David Halbert is now a newly minted biotech billionaire worth an estimated $3.3 billion, Forbes reports.
MORE
Irving’s Caris Life Sciences Files for IPO, Backed by AI-Driven Precision Oncology Platform
by | May 28, 2025
With $1.86 billion raised since 2018 and recent product launches, the North Texas life science company founded in 2008 is preparing for a public debut on the Nasdaq Global Select Market, following a $168 million growth capital round in April.
MORE
Dallas-Based DataBank Gets $250M Equity Investment from TJC, Announces $600M Secondary Share Sale
by | Jan 30, 2025
DataBank—a data center company providing edge colocation, interconnection, and managed services—said the new funding resulted from "excess investor interest" in its recent $2 billion primary equity round. Total debt and equity raised by DataBank in the past 18 months: nearly $5 billion.
MORE
Dallas-Based DataBank Announces $2B Equity Raise Led by $1.5B from AustralianSuper
by | Oct 15, 2024
DataBank—which recently announced a planned 480MW data center campus south of Dallas—said the capital raise was oversubscribed and, in addition to the $1.5 billion from AustralianSuper, included another $483 million in commitments from "existing investors."
MORE